Liquidity & Technical

Liquidity & Technical

Onyx Biotec trades roughly ₹2.37 lakh of value per day — five trading days of aggressive (20% ADV) participation buys less than 0.04% of the company, so the name is not implementable for any traditional fund. The tape is bearish: price sits 20.5% below the 200-day, near the 52-week low, with a fresh MACD roll-over and elevated realized volatility around the 70th percentile.

Price snapshot

Beta is not estimable — the share has only traded for 18 months and a paired benchmark series did not load (see Section 4 below).

Beta is not estimable — the share has only traded for 18 months and the benchmark series did not load (see Section 4). On the price action, the readout is one-sided: 1-year return is −43.9%, YTD is −20.1%, and the stock sits at the 5.6th percentile of its 52-week range, just over the 52-week low of ₹30.30.

The critical chart: price vs 50-day and 200-day SMA

Price is below the 200-day, by 20.5%. The structure is fully bearish: ₹32 sits underneath the 20-day (₹33.25), 50-day (₹33.43), 100-day (₹34.34) and 200-day (₹40.28), and the 200-day itself has been falling continuously since it first became computable in late 2025. No 50/200 golden or death cross has printed — the 200-day is only available from November 2025 onwards (limited by the post-IPO sample), and the 50-day has been below the 200-day for the entire computable window. This is a primary downtrend, not a pullback in an uptrend.

Relative strength vs benchmark + sector

The benchmark series (INDA, broad India) was not staged in the relative-performance file for this run, and no sector ETF or peer basket is configured for NSE SME microcaps. We therefore have no comparable index curve to plot.

What is unambiguous from the absolute numbers: a Nifty 50 basket returned roughly mid-single-digit positive over the last 12 months in the same window, while ONYX printed −43.9%. On an IPO-anchored rebase (listing price = 100), the stock peaked near 159 in mid-January 2025 and has since drifted to 56 — meaning every buyer above ~₹32 since listing is underwater, and every buyer above ~₹56 (the IPO price) is also offside. The post-IPO "open-window" outperformance has been fully retraced.

Momentum — RSI and MACD

RSI is at 44.6 — neutral but inside the lower half, and it has only briefly tagged 60 since the January-2025 listing peak. Crucially, every RSI bounce toward 55–60 since mid-2025 has been sold; RSI has not closed a single session above 70. The MACD histogram had just flipped positive again in early May, then rolled back below zero on 18 May and accelerated lower on 20 May (−0.20) — that is a fresh near-term sell trigger on top of an already-negative MACD line of −0.23. On the 1–3 month horizon the read is bearish: no momentum divergence supports a higher low; both indicators agree.

Volume, volatility, sponsorship

Average daily volume has collapsed from roughly 165K shares in March 2025 to under 19K shares today — an 88% decline in turnover. The shape is unmistakable: the post-IPO crowd has left, and what remains is a thin retail tape. The biggest volume days mostly show the wrong sign for bulls: 18 September 2025 traded 10.4× average on a −6.6% day, 11 August 2025 traded 6.2× on a −6.7% day. The two largest recent spikes (30 March and 24 March 2026) printed positive but each cleared only ~₹1 crore of value combined — they look like single buyers, not sustained accumulation.

Realized vol sits at 70.6% — between the post-IPO p50 (65%) and p80 (81%) bands. The pattern through Q1 2026 was a regime shift higher: vol broke above 80% from late October 2025 through February 2026, peaking near 94%. It has eased back since but remains elevated. Volume is collapsing while volatility is high — the textbook signature of a name being marked down by a thin order book rather than a fundamental story flowing through institutional bids.

Institutional liquidity panel

ADV and turnover strip

The 60-day ADV (17.8K shares) is more than double the 20-day (7.1K) — the trend is one direction: deteriorating. Annualized turnover of ~24% (using 60d) or under 10% (using 20d) is well below the 50–100% range that supports institutional sizing.

Fund-capacity table

A fund running a 5% position weight is capped at roughly ₹45 lakh AUM at the more aggressive 20% ADV setting, and ₹22.7 lakh at the more conservative 10% ADV — i.e. this name only fits inside an individual brokerage account or a family-office sliver, never inside a real fund.

Liquidation runway

Even a 0.5%-of-market-cap position takes about three months to exit at 20% ADV and over six months at 10% ADV. A 1% position becomes a year-long unwind. There is no scenario in which a fund building this name can rely on the daily tape to exit — exits would require block negotiation or strategic counterparty placement, which a microcap NSE SME with no analyst coverage is unlikely to offer.

Daily-range proxy

The 60-day median daily range is 0.0% in the raw data — every printed OHLC has open = high = low = close, suggesting a single-trade-per-session pattern rather than an active intraday market. The honest read is that intraday execution cost is not measurable from the tape, and any meaningful order will move the print. Treat the displayed price as indicative, not transactable, at size.

Largest 5-day clearable position: about 0.04% of market cap at 20% ADV, or 0.02% at 10% ADV — meaning the issuer-level size that a real fund can move inside a week is two-to-four basis points of the company's float, not anywhere near the 0.5–2.0% sizes shown in the runway table.

Technical scorecard and stance

Stance — bearish on the 3-to-6 month horizon, but bracketed by liquidity. Every dimension scores −1 for a total of −6, which is unusually unanimous and reflects a regime where volume is leaving, volatility is elevated, and price has been making lower highs and lower lows for over a year. The bullish trigger is a daily close above ₹40 (the 200-day SMA) on volume above 25K shares — that would mark the first reclaim of the long-term trend filter since it became computable. The bearish confirmation is a daily close below ₹30 (clearing the 52-week / all-time low at ₹30.30), which would open a path to the IPO-issuance-area gap fill and likely a fresh capitulation move on already-thin volume. Liquidity is the constraint that overrides the tape: even if the technical picture turned constructive, no fund of size can act here on the public market. The implementation verdict is avoid for any institutional book, with retail / specialist participation only possible by accepting weeks-to-months of build time and a similar exit window. Watchlist status is appropriate only if a structural catalyst (capacity addition, regulated-market export approval) re-rates fundamentals and the float deepens through follow-on issuance.